InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Lindahl Richard S, Chief Financial Officer. Officer active across 1 company, notably Emergent BioSolutions Inc.. Cumulatively, 23 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €98k. History available since 8 May 2021. The latest transaction was disclosed on 29 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Lindahl Richard S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
3,964 sharesCommon StockSEC:0001196632-26-000017:0
162,680 shares0Common StockSEC:0001196632-26-000013:0
23,650 shares@ US$8.4419.0% of flowCommon StockSEC:0001196632-26-000009:0
683 shares@ US$8.150.5% of flowCommon StockSEC:0001196632-26-000006:0
46,155 shares@ US$10.9247.4% of flowCommon StockSEC:0001196632-26-000003:0
4,995 shares@ US$9.6013.8% of flowCommon StockSEC:0001196632-25-000004:0
2,733 shares@ US$6.636.2% of flowCommon StockSEC:0001367644-25-000138:0
146,888 shares0Common StockSEC:0001367644-25-000051:0
16,916 shares0Common StockSEC:0001367644-25-000030:0
15,000 shares0Common StockSEC:0001367644-24-000164:0
2,733 shares@ US$6.193.9% of flowCommon StockSEC:0001367644-24-000105:0
9,037 shares@ US$3.236.8% of flowCommon StockSEC:0001367644-24-000021:0
4,012 shares@ US$2.712.5% of flowCommon StockSEC:0001367644-24-000008:0
24,616 shares0Common StockSEC:0001367644-23-000122:0
6,154 shares0Common StockSEC:0001367644-23-000068:0
1,074 shares@ US$12.383.2% of flowCommon StockSEC:0001367644-23-000057:0
444 shares@ US$14.301.5% of flowCommon StockSEC:0001367644-23-000035:0
101 shares0Common StockSEC:0001367644-23-000014:0
31,417 shares0Common StockSEC:0001367644-22-000042:0
516 shares@ US$42.230.0047% mcap5.9% of flowCommon StockSEC:0001367644-22-000032:0
1,836 shares0Common StockSEC:0001367644-22-000020:0
3,000 shares@ US$37.4610.9% of flowCommon StockSEC:0001367644-21-000144:0
Canonical exit: 13 Feb 2022 (T+90)
1,054 shares@ US$61.626.0% of flowCommon StockSEC:0001367644-21-000079:0
23 of 23 declarations
About Lindahl Richard S
LINDAHL RICHARD S is Directeur Financier and EVP, Chief Financial Officer at Emergent BioSolutions Inc. Across 23 filings recorded, the 23 sampled filings cover the period from 2021-05-11 to 2026-06-10, with buys of EUR 98220 and sells of EUR 437987, and the most frequent transaction nature shown is Retenue fiscale.
